Our Speakers

Specificities of the Greek Healthcare System

The healthcare system in Greece combines universal public services and a vibrant private sector, providing diverse options to citizens and residents. While it ensures broad access to care through ESY and EOPYY insurance, it faces challenges such as lack of resources, long waiting times, and inequalities in access to services. Despite these limitations, the system remains an important safety net, with an orientation towards improvement through progressive reforms and investments.

Kyriakos Souliotis, Professor of Health Policy, Dean of the School of Social & Political Sciences, Director, Laboratory for the Evaluation of Health Policies, Technologies & Behaviors, University of Peloponnese, Corinth, Greece

axunio – empowering the overlooked patient

In this presentation, we would like to present our company. We, axunio Pharma GmbH, sell and promote pharmaceuticals in our home market Germany, as well as in the UK, Scandinavia, and the Netherlands. We launched our first product in 2016 and have accomplished major milestones ever since. Our mission is to identify minority needs, which tend to be overlooked. Therefore, we are continuously looking for niche and/or value-added products to in-license or acquire (including the brand). The latter applies to UK in particular, as we are planning to open up our own office there. We believe in targeted and outside-the-box marketing approaches that are built on thorough market analysis and close relationships with KOL from the respective medical areas.

Julia Von Horsten, Business Development Manager, axunio Pharma GmbH

Ina Kühnemund, Managing Director, axunio Pharma GmbH

Farmasyn : “We put the patient first”

FarmaSyn S.A. is a company committed to delivering innovative, accessible, and reliable therapeutic solutions. Established in 1994, FarmaSyn has grown through strategic alliances with international leaders, including Cheplapharm, Engelhard, Sandoz and IBSA. Certified to the most exacting European standards, FarmaSyn’s prioritization of quality and patient trust has established it as a dependable partner for healthcare providers and patients in Greece.

Nikolaos Makrigiannis, Business Development Manager, FarmaSyn SA

Reviving & upgrading old molecules: Challenges & Opportunities

The speaker will address the main challenges faced when upgrading or developing the registration dossier for an old molecule. He will then elaborate on the opportunities which some of these old molecules present and the partners Medochemie seeks to commercialise such molecules.

Andreas Loizou, Group Business Development Director,Medochemie Ltd.

AI in Pharma: a transformative Pilot in Market Access

This session will provide you with valuable insights into how AI can transform your operations today and prepare you for tomorrow’s challenges in critical fields like regulatory affairs and quality management.
You will also discover CLEVAIR-HTA, our advanced AI solution designed to support your market access needs while paving the way for broader integration tailored to the unique needs of small and medium-sized pharmaceutical companies.

Henry Jonckheere and Marc Czarka, Administrators MAEVH sas